• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一般人群中,非传染性疾病的终身风险和多病共存及无疾病预期寿命:基于人群的队列研究。

Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study.

机构信息

Department of Epidemiology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.

Department of Neurology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.

出版信息

PLoS Med. 2019 Feb 4;16(2):e1002741. doi: 10.1371/journal.pmed.1002741. eCollection 2019 Feb.

DOI:10.1371/journal.pmed.1002741
PMID:30716101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6361416/
Abstract

BACKGROUND

Non-communicable diseases (NCDs) are leading causes of premature disability and death worldwide. However, the lifetime risk of developing any NCD is unknown, as are the effects of shared common risk factors on this risk.

METHODS AND FINDINGS

Between July 6, 1989, and January 1, 2012, we followed participants from the prospective Rotterdam Study aged 45 years and older who were free from NCDs at baseline for incident stroke, heart disease, diabetes, chronic respiratory disease, cancer, and neurodegenerative disease. We quantified occurrence/co-occurrence and remaining lifetime risk of any NCD in a competing risk framework. We additionally studied the lifetime risk of any NCD, age at onset, and overall life expectancy for strata of 3 shared risk factors at baseline: smoking, hypertension, and overweight. During 75,354 person-years of follow-up from a total of 9,061 participants (mean age 63.9 years, 60.1% women), 814 participants were diagnosed with stroke, 1,571 with heart disease, 625 with diabetes, 1,004 with chronic respiratory disease, 1,538 with cancer, and 1,065 with neurodegenerative disease. NCDs tended to co-occur substantially, with 1,563 participants (33.7% of those who developed any NCD) diagnosed with multiple diseases during follow-up. The lifetime risk of any NCD from the age of 45 years onwards was 94.0% (95% CI 92.9%-95.1%) for men and 92.8% (95% CI 91.8%-93.8%) for women. These risks remained high (>90.0%) even for those without the 3 risk factors of smoking, hypertension, and overweight. Absence of smoking, hypertension, and overweight was associated with a 9.0-year delay (95% CI 6.3-11.6) in the age at onset of any NCD. Furthermore, the overall life expectancy for participants without these risk factors was 6.0 years (95% CI 5.2-6.8) longer than for those with all 3 risk factors. Participants aged 45 years and older without the 3 risk factors of smoking, hypertension, and overweight at baseline spent 21.6% of their remaining lifetime with 1 or more NCDs, compared to 31.8% of their remaining life for participants with all of these risk factors at baseline. This difference corresponds to a 2-year compression of morbidity of NCDs. Limitations of this study include potential residual confounding, unmeasured changes in risk factor profiles during follow-up, and potentially limited generalisability to different healthcare settings and populations not of European descent.

CONCLUSIONS

Our study suggests that in this western European community, 9 out of 10 individuals aged 45 years and older develop an NCD during their remaining lifetime. Among those individuals who develop an NCD, at least a third are subsequently diagnosed with multiple NCDs. Absence of 3 common shared risk factors is associated with compression of morbidity of NCDs. These findings underscore the importance of avoidance of these common shared risk factors to reduce the premature morbidity and mortality attributable to NCDs.

摘要

背景

非传染性疾病(NCDs)是全球导致过早残疾和死亡的主要原因。然而,人们并不清楚一生中患上任何一种 NCD 的风险有多大,也不知道共同存在的危险因素对这种风险的影响有多大。

方法和发现

1989 年 7 月 6 日至 2012 年 1 月 1 日期间,我们对前瞻性鹿特丹研究中的参与者进行了随访,这些参与者年龄在 45 岁及以上,在基线时没有 NCD,他们的研究终点是中风、心脏病、糖尿病、慢性呼吸道疾病、癌症和神经退行性疾病。我们在竞争风险框架下量化了任何 NCD 的发病/共病情况和剩余终生风险。此外,我们还研究了任何 NCD 的终生风险、发病年龄和基线时 3 个共同危险因素(吸烟、高血压和超重)的总体预期寿命。在 9061 名参与者(平均年龄 63.9 岁,60.1%为女性)的 75354 人年随访中,814 名参与者被诊断患有中风,1571 名患有心脏病,625 名患有糖尿病,1004 名患有慢性呼吸道疾病,1538 名患有癌症,1065 名患有神经退行性疾病。从 45 岁开始,NCD 往往会大量共同发生,1563 名参与者(所有患有任何 NCD 者的 33.7%)在随访期间被诊断患有多种疾病。从 45 岁开始,男性任何 NCD 的终生风险为 94.0%(95%CI 92.9%-95.1%),女性为 92.8%(95%CI 91.8%-93.8%)。即使是那些没有吸烟、高血压和超重这 3 个危险因素的人,这些风险仍然很高(>90.0%)。没有吸烟、高血压和超重与任何 NCD 发病年龄延迟 9.0 年相关(95%CI 6.3-11.6)。此外,没有这些危险因素的参与者的总体预期寿命比那些有 3 个危险因素的参与者长 6.0 年(95%CI 5.2-6.8)。在基线时没有吸烟、高血压和超重这 3 个危险因素的 45 岁及以上的参与者,在其剩余的寿命中有 21.6%的时间患有 1 种或多种 NCD,而在基线时同时具有这 3 个危险因素的参与者中,这一比例为 31.8%。这种差异相当于 NCD 发病年龄的 2 年压缩。本研究的局限性包括潜在的残余混杂因素、随访期间危险因素谱的未测量变化,以及可能对不同的医疗保健环境和非欧洲裔人群的普遍适用性有限。

结论

我们的研究表明,在这个西欧社区,45 岁及以上的人群中,每 10 人中有 9 人在其剩余的一生中会患上某种 NCD。在那些患上 NCD 的人中,至少有三分之一的人随后被诊断患有多种 NCD。没有 3 个常见的共同危险因素与 NCD 发病年龄的压缩有关。这些发现强调了避免这些常见的共同危险因素的重要性,以减少 NCD 导致的过早发病和死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/fab75e2fb3a1/pmed.1002741.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/0e8c2504596b/pmed.1002741.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/6947c47e22d2/pmed.1002741.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/ec750f64da77/pmed.1002741.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/5488665751e3/pmed.1002741.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/fab75e2fb3a1/pmed.1002741.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/0e8c2504596b/pmed.1002741.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/6947c47e22d2/pmed.1002741.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/ec750f64da77/pmed.1002741.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/5488665751e3/pmed.1002741.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9898/6361416/fab75e2fb3a1/pmed.1002741.g005.jpg

相似文献

1
Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study.一般人群中,非传染性疾病的终身风险和多病共存及无疾病预期寿命:基于人群的队列研究。
PLoS Med. 2019 Feb 4;16(2):e1002741. doi: 10.1371/journal.pmed.1002741. eCollection 2019 Feb.
2
Thyroid function and life expectancy with and without noncommunicable diseases: A population-based study.甲状腺功能与有无非传染性疾病患者的预期寿命:一项基于人群的研究。
PLoS Med. 2019 Oct 25;16(10):e1002957. doi: 10.1371/journal.pmed.1002957. eCollection 2019 Oct.
3
Disease Burden and the Accumulation of Multimorbidity of Noncommunicable Diseases in a Rural Population in Henan, China: Cross-sectional Study.中国河南省农村人口的非传染性疾病疾病负担和多种疾病的积累:横断面研究。
JMIR Public Health Surveill. 2023 May 22;9:e43381. doi: 10.2196/43381.
4
Burden of non-communicable diseases from infectious causes in 2017: a modelling study.2017 年由传染性病因导致的非传染性疾病负担:一项建模研究。
Lancet Glob Health. 2020 Dec;8(12):e1489-e1498. doi: 10.1016/S2214-109X(20)30358-2. Epub 2020 Oct 21.
5
Association Between Adherence to 24-Hour Movement Guidelines and Noncommunicable Disease Risk in Chinese Adults: Prospective Cohort Study.《中国成年人遵循 24 小时身体活动指南与非传染性疾病风险的关系:前瞻性队列研究》
JMIR Public Health Surveill. 2024 Mar 27;10:e47517. doi: 10.2196/47517.
6
Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.1990-2017 年 195 个国家和地区可避免的非传染性疾病过早死亡率趋势:基于人群的研究。
Lancet Glob Health. 2020 Apr;8(4):e511-e523. doi: 10.1016/S2214-109X(20)30035-8.
7
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.NCD 倒计时 2030:全球非传染性疾病死亡率趋势及实现可持续发展目标 3.4 目标进展。
Lancet. 2018 Sep 22;392(10152):1072-1088. doi: 10.1016/S0140-6736(18)31992-5. Epub 2018 Sep 20.
8
[Estimation of the impact of risk factors control on non-communicable diseases mortality, life expectancy and the labor force lost in China in 2030].[2030年中国危险因素控制对非传染性疾病死亡率、预期寿命及劳动力损失的影响评估]
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Dec 6;51(12):1079-1085. doi: 10.3760/cma.j.issn.0253-9624.2017.12.006.
9
Ethnic disparities in prevalence of chronic non-communicable diseases and its multimorbidity among older adults in rural southwest China.中国西南农村老年人中慢性非传染性疾病及其多种疾病的流行率存在种族差异。
BMC Public Health. 2023 Jun 23;23(1):1217. doi: 10.1186/s12889-023-16161-1.
10
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.非传染性疾病、社会人口因素与感染死亡风险:英国生物银行观察性队列研究。
Lancet Infect Dis. 2021 Aug;21(8):1184-1191. doi: 10.1016/S1473-3099(20)30978-6. Epub 2021 Mar 1.

引用本文的文献

1
Healthy lifestyle and life expectancy with and without major chronic disease - a cohort study.有或无主要慢性病情况下的健康生活方式与预期寿命——一项队列研究
Sci Rep. 2025 Jul 29;15(1):27691. doi: 10.1038/s41598-025-11093-9.
2
Chronic kidney disease and dementia: an epidemiological perspective.慢性肾脏病与痴呆:流行病学视角
Nat Rev Nephrol. 2025 May 22. doi: 10.1038/s41581-025-00967-w.
3
Modeling the spectrum and determinants of multimorbidity risk among older adults in India.模拟印度老年人多重疾病风险的谱图和决定因素。

本文引用的文献

1
Lifetime risk of common neurological diseases in the elderly population.老年人常见神经疾病的终生发病风险。
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):148-156. doi: 10.1136/jnnp-2018-318650. Epub 2018 Oct 2.
2
Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.中年人及老年人的哮喘及其合并症;鹿特丹研究。
Respir Med. 2018 Jun;139:6-12. doi: 10.1016/j.rmed.2018.04.006. Epub 2018 Apr 11.
3
Making more of multimorbidity: an emerging priority.重视多重疾病:一个新出现的优先事项。
PLoS One. 2025 May 16;20(5):e0323744. doi: 10.1371/journal.pone.0323744. eCollection 2025.
4
Ageing, multimorbidity, and quality of life: a mediation analysis using longitudinal ageing study in India.衰老、多种疾病并存与生活质量:一项基于印度纵向衰老研究的中介分析
Front Public Health. 2025 Apr 25;13:1562479. doi: 10.3389/fpubh.2025.1562479. eCollection 2025.
5
Physical health in young males and risk of chronic musculoskeletal, cardiovascular, and respiratory diseases by middle age: A population-based cohort study.年轻男性的身体健康状况与中年时慢性肌肉骨骼疾病、心血管疾病和呼吸系统疾病的风险:一项基于人群的队列研究。
PLoS Med. 2025 Jan 21;22(1):e1004517. doi: 10.1371/journal.pmed.1004517. eCollection 2025 Jan.
6
The current landscape of personalised preventive approaches for non-communicable diseases: A scoping review.非传染性疾病个性化预防方法的现状:一项范围综述
PLoS One. 2025 Jan 13;20(1):e0317379. doi: 10.1371/journal.pone.0317379. eCollection 2025.
7
Influencing factor analysis of family doctor contract service among older adults: evidence from China.老年人家庭医生签约服务的影响因素分析:来自中国的证据
Front Public Health. 2024 Nov 19;12:1487365. doi: 10.3389/fpubh.2024.1487365. eCollection 2024.
8
High free sugars, insulin resistance, and low socioeconomic indicators: the hubs in the complex network of non-communicable diseases in adolescents.高游离糖、胰岛素抵抗和低社会经济指标:青少年非传染性疾病复杂网络中的核心因素。
Diabetol Metab Syndr. 2024 Sep 28;16(1):235. doi: 10.1186/s13098-024-01469-8.
9
Association between polypharmacy and 2-year outcomes among Chinese older inpatients: a multi-center cohort study.中文老年住院患者药物治疗方案种类与 2 年结局的相关性:一项多中心队列研究。
BMC Geriatr. 2024 Sep 9;24(1):748. doi: 10.1186/s12877-024-05340-3.
10
The Association between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study.尿路上皮癌患者糖尿病药物使用与诊断时肿瘤特征之间的关联:一项基于回顾性登记的研究。
Bladder Cancer. 2023 Mar 31;9(1):73-82. doi: 10.3233/BLC-220082. eCollection 2023.
Lancet. 2018 Apr 28;391(10131):1637. doi: 10.1016/S0140-6736(18)30941-3. Epub 2018 Apr 26.
4
Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.投资于非传染性疾病:预防和治疗服务投资回报的估计。
Lancet. 2018 May 19;391(10134):2071-2078. doi: 10.1016/S0140-6736(18)30665-2. Epub 2018 Apr 5.
5
Lower-Income Countries That Face The Most Rapid Shift In Noncommunicable Disease Burden Are Also The Least Prepared.面临非传染性疾病负担最快转变的低收入国家也是准备最不充分的国家。
Health Aff (Millwood). 2017 Nov;36(11):1866-1875. doi: 10.1377/hlthaff.2017.0708.
6
The Rotterdam Study: 2018 update on objectives, design and main results.鹿特丹研究:2018年目标、设计与主要结果的最新情况
Eur J Epidemiol. 2017 Sep;32(9):807-850. doi: 10.1007/s10654-017-0321-4. Epub 2017 Oct 24.
7
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 84 种行为、环境和职业以及代谢风险或风险组合的比较风险评估,1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8.
8
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家按年龄、性别划分的 264 种死因的死亡率:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9.
9
Obesity and Life Expectancy with and without Diabetes in Adults Aged 55 Years and Older in the Netherlands: A Prospective Cohort Study.荷兰55岁及以上成年人中患糖尿病与未患糖尿病情况下的肥胖与预期寿命:一项前瞻性队列研究
PLoS Med. 2016 Jul 19;13(7):e1002086. doi: 10.1371/journal.pmed.1002086. eCollection 2016 Jul.
10
Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.普通人群中帕金森病的发病率趋势:鹿特丹研究
Am J Epidemiol. 2016 Jun 1;183(11):1018-26. doi: 10.1093/aje/kwv271. Epub 2016 Apr 29.